Experts

Jesus Ching is a scientist, inventor, and entrepreneur with over 30 years of experience andmore than 50 patents spanning molecular diagnostics, genomics, proteomics, andCRISPR-based technologies. A true pioneer in next-generation diagnostics, Jesus has built acareer transforming scientific innovation into clinically impactful, commercially successfulproducts.He has founded multiple diagnostics companies, three of which were acquired by industryleaders Bio-Rad, Luminex/DiaSorin, and Cepheid/Danaher. His deep technicalexpertise—combined with a relentless focus on first-principles thinking—has led to the creationand launch of numerous products across point-of-care, lab-based, and multi-omic testingplatforms that redefine what’s possible in human diagnostics.At Xella Health, Jesus leads the company’s scientific and technological vision, applying hisdecades of experience in molecular systems design to power Xella’s AI- and multi-omic-basedprecision health platform for women. Jesus holds a PhD in Chemistry from Baylor University anda BS in Biology and Chemistry from Houston Baptist University.

Adriana Dantas is a global biotech and medical-device leader with more than 20 years ofexperience bringing breakthrough technologies from bench to bedside. A biochemist andpharmacist turned business strategist, she has built a career at the intersection of science,operations, and commercialization—bridging research innovation with real-world impact.Before co-founding Xella Health, Adriana held senior executive roles at Roche, BectonDickinson, and Mammoth Biosciences, where she led cross-functional teams spanning R&D,operations, and go-to-market execution. Her leadership has guided product portfolios thatachieved first- and second-in-market share positions globally, and she has lived and led acrossfive countries, cultivating a truly international perspective on healthcare delivery and innovation.One of her proudest achievements was leading the women's health division at Roche, includingthe acquisition and multinational rollout of the Ariosa line for non-invasive prenatal testing.She holds an MBA from FGV (Brazil) and Cranfield School of Management (UK), and aDoctorate in Pharmacy and Biochemistry from the University of São Paulo.